Axogen, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
AXGN on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
13631 Progress Blvd., Suite 400, Alachua, FL

Insiders trading volume in the past year

Axogen, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Karen L. Zaderej CEO, Director $8.78M Mar 16, 2024
Michael Dale Chief Executive Officer $6.54M Mar 25, 2025
Erick DeVinney Chief Innovation Officer $4.48M -$264K -5.58% Mar 25, 2025
Nir Naor Cfo $3.97M Jan 6, 2025
Mark Gold Director $2.45M Jun 1, 2022
Gregory Gene Freitag Director $2.32M Jun 4, 2024
Amy Wendell Director $2.09M -$100K -4.58% Mar 3, 2025
Peter J. Mariani EVP & Chief Financial Officer $1.9M Dec 11, 2023
Marc Began EVP & General Counsel $1.3M Mar 25, 2025
Eric Sandberg Chief Commercial Officer $1.22M Jul 18, 2022
Jens Kemp Chief Marketing Officer $1.17M Mar 25, 2025
Guido J. Neels Director $1M Sep 1, 2024
Mark Friedman VP Regulatory Affairs & Policy $797K Mar 16, 2022
Kathy Weiler Director $700K Jun 6, 2024
Maria D. Martinez Chief Human Resources Officer $695K Jul 18, 2023
Alan M. Levine Director $619K Sep 1, 2024
Michael Patrick Donovan VP Operations $581K Mar 16, 2024
John Johnson Director $528K Sep 1, 2024
Joseph A. Tyndall Director $479K +$26.5K +5.86% Dec 31, 2024
Angelo Scopelianos Chief R&D Officer $445K Mar 16, 2024
Paul Thomas Director $432K Sep 16, 2024
Isabelle Billet Chief Strategy and BD Officer $383K Dec 27, 2022
William Burke Director $383K Sep 1, 2024
Quentin S. Blackford Director $247K Mar 30, 2022
Bradley Ottinger General Counsel and CCO $200K Mar 16, 2023

Recent Insider Transactions by Companies or Individuals for Axogen, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.